Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial
暂无分享,去创建一个
M. Parmar | A. Oza | J. Ledermann | G. Jayson | H. Hirte | G. Rustin | M. Friedlander | S. Kaye | R. Kaplan | T. Perren | A. Swart | M. Vaughan | L. Farrelly | A. González-Martín | A. Embleton-Thirsk | B. Popoola | E. Deane